Maple Ridge, Canada Clinical Trials

A listing of Maple Ridge, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis (PsO) is a chronic disease characterized by marked inflammation of the skin that results in thick, red, scaly plaques. This study will assess how safe and effective risankizumab is compared to apremilast in adult participants with moderate plaque psoriasis. Adverse events and change in disease symptoms will be monitored. …

plaque psoriasis
systemic therapy
arthritis
risankizumab
apremilast
Dr. Chih-ho Hong Medical Inc. /ID# 230337
 (9.2 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +61 other locations
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

The purpose of this study is to evaluate the long-term safety and maintenance of efficacy of mirikizumab in participants with moderate-to-severe plaque psoriasis.

mirikizumab
plaque psoriasis
Dr. Chih-ho Hong Medical Inc.
 (9.2 away) Contact site
  • 717 views
  • 27 Jul, 2021
  • +354 other locations
A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

The purpose of this study is to evaluate the effectiveness and safety of 3 dose regimen of CC-93538 in adult participants with moderate to severe Atopic Dermatitis (AD).

ultraviolet light
corticosteroids
asthma
montelukast
topical agents
Dr. Chih-ho Hong Medical Inc.
 (9.2 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +84 other locations
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo

Vitiligo is a common chronic autoimmune disease that causes the body's immune system to attack its own pigment producing skin cells. This study is to evaluate how safe and effective upadacitinib is in participants with non-segmental vitiligo. Adverse effects and change in disease activity will be assessed. Upadacitinib is being …

Dr. Chih-ho Hong Medical Inc. /ID# 228403
 (9.2 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +43 other locations
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in pediatric subjects with moderate to severe plaque psoriasis. At least 230 pediatric subjects (ages 6 through 17 years) will be randomized 2:1 to receive either apremilast or placebo for the first …

cc-10004
plaque psoriasis
systemic therapy
apremilast
topical agents
Research Site
 (9.2 away) Contact site
  • 98 views
  • 04 Aug, 2021
  • +284 other locations
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This 110-week study is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis.

topical agents
eczema
progestogen
hormonal contraception
lebrikizumab
Dr. Chih-ho Hong Medical Inc.
 (9.2 away) Contact site
  • 154 views
  • 31 Jul, 2021
  • +346 other locations
Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Plaque Psoriasis is a chronic inflammatory disease in which skin cells build up and develop scaly red and white patches on the skin. It is caused by an overactive immune system where the body attacks healthy tissue by mistake. Palmoplantar (non-pustular) plaque psoriasis (PPPsO) represents a localized form of psoriasis …

plaque psoriasis
systemic therapy
arthritis
risankizumab
phototherapy
Dr. Chih-ho Hong Medical Inc. /ID# 220941
 (9.2 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +69 other locations
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis

This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).

eczema
baricitinib
topical agents
ly3009104
Dr. Chih-ho Hong Medical Inc.
 (9.2 away) Contact site
  • 0 views
  • 25 Jul, 2021
  • +75 other locations